Background: New treatment modalities are urgently needed for patients with COVID-19. The
World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or …

The association between pulmonary sequelae and markers of disease severity, as well as
pro-fibrotic mediators, were studied in 108 patients 3 months after hospital admission for …

Background Although coronavirus disease 2019 (COVID‐19) is primarily a respiratory
infection, mounting evidence suggests that the gastrointestinal tract is involved in the disease, …

Despite numerous studies on SARS-CoV-2-induced inflammation, we still lack markers for
rapid disease progression with admission to intensive care unit (ICU) or respiratory failure (RF…

Objective Although COVID-19 is primarily a respiratory infection, mounting evidence suggests
that the GI tract is involved in the disease, with gut barrier dysfunction and gut microbiota …

Background: There is an urgent need for new treatment modalities in COVID-19 patients.
Recently, the WHO Solidarity trial showed no effects of remdesivir or hydroxychloroquine (HCQ…

We read with interest the article by Yang et al. suggesting no significant association between
dyslipidemia and COVID-19 mortality 1. However, whereas most studies have focused on …

Background Immune dysregulation is a major factor in the development of severe coronavirus
disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 have been …

… Haugli er professor i rettsvitenskap og har arbeidet med barnerettslige spørsmål i nærmere
30 år. Dette i hovedsak i form av forskning og undervisning, men også gjennom fem års …